Synchronous papillary thyroid carcinoma and breast ductal carcinoma

被引：5

作者：

Kong, Heng ^{[1
,2
]}

Chen, JiXin ^{[2
]}

Tang, Shou-Ching ^{[3
]}

机构：

[1] Shenzhen Univ, Affiliated Hosp 5, Baoan Cent Hosp Shenzhen, Dept Thyroid & Breast Surg, 233 Xixiang Sect Guangshen Ave, Shenzhen 518102, Guangdong, Peoples R China

[2] Shenzhen Univ, Shenzhen Univ Gen Hosp, Dept Gen Surg, Shenzhen, Peoples R China

[3] Univ Mississippi, Med Ctr, Canc Ctr & Res Inst, Clin & Translat Res, Guyton Res Bldg,2500 North State St, Starkville, MS USA

来源：

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2020年 / 48卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Breast; thyroid; synchronous cancer; endocrine hormone; chemotherapy; mastectomy; PRIMARY CANCERS; HORMONES; ASSOCIATION; EXPRESSION; DISEASE;

D O I：

10.1177/0300060520948710

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

A 48-year-old woman was admitted to our hospital with a lump in her left breast. She was diagnosed with synchronous papillary thyroid carcinoma and breast ductal carcinoma. The patient underwent four cycles of neoadjuvant chemotherapy with epirubicin and cyclophosphamide, and one cycle of docetaxel. She then underwent left breast mastectomy and radical resection of thyroid cancer (total thyroidectomy and bilateral central group [levels VI and VII] lymph node dissection) at the same time. She was administered three cycles of chemotherapy with docetaxel and radiotherapy. The patient had no metastasis in the follow-up period. A literature search was performed to characterize the epidemiology, etiology, management, and prognosis of this condition. We speculate that hormone treatment could be a probable pathogenesis of synchronous breast and thyroid cancers.

引用

页数：6

共 18 条

[1] Aluclu Mustafa Arif, 2016, Afr J Paediatr Surg, V13, P136, DOI 10.4103/0189-6725.187812
[2] Retrospective Analysis of Patients with Synchronous Primary Breast and Thyroid Carcinoma
Arer, Ilker Murat
Yabanoglu, Hakan
Kus, Murat
Akdur, Aydincan
Avci, Tevfik
[J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2018, 14 (02) : 80 - 84
[3] FERNANDEZ-POL J A, 1991, Critical Reviews in Oncogenesis, V2, P173
[4] Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
Fisher, DA
[J]. THYROID, 1999, 9 (07) : 715 - 720
[5] Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer
Gadducci, A
Biglia, N
Sismondi, P
Genazzani, AR
[J]. GYNECOLOGICAL ENDOCRINOLOGY, 2005, 20 (06) : 343 - 360
[6] Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Gebhart, G.
Lamberts, L. E.
Wimana, Z.
Garcia, C.
Emonts, P.
Ameye, L.
Stroobants, S.
Huizing, M.
Aftimos, P.
Tol, J.
Oyen, W. J. G.
Vugts, D. J.
Hoekstra, O. S.
Schroder, C. P.
van Oordt, C. W. Menke-van der Houven
Guiot, T.
Brouwers, A. H.
Awada, A.
de Vries, E. G. E.
Flamen, P.
[J]. ANNALS OF ONCOLOGY, 2016, 27 (04) : 619 - 624
[7] Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy
Giani, C
Fierabracci, P
Bonacci, R
Gigliotti, A
Campani, D
DeNegri, F
Cecchetti, D
Martino, E
Pinchera, A
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) : 990 - 994
[8] Benign thyroid disease is associated with breast cancer: a meta-analysis
Hardefeldt, Prue J.
Eslick, Guy D.
Edirimanne, Senarath
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1169 - 1177
[9] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
Haugen, Bryan R.
[J]. CANCER, 2017, 123 (03) : 372 - 381
[10] Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database
Kuo, Jennifer H.
Chabot, John A.
Lee, James A.
[J]. SURGERY, 2016, 159 (01) : 23 - 29

← 1 2 →